Quality Improvement Grant for Non-Small Cell Lung Cancer Therapy Management for Optimal Outcomes (Middle East)

Projects that will be considered for Pfizer support will focus on development of an algorithm or tool to guide the optimal treatment and support of patients with ALK re- arranged NSCLC.